Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
36°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SNY
Recent news which mentions SNY
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Earnings Scheduled For February 1, 2024
February 01, 2024
Tickers
AAPL
ALGM
AMZN
ATI
Tags
Benzinga
LPLA
ETN
From
Benzinga
Sanofi's Earnings Outlook
January 31, 2024
Tickers
SNY
Tags
Market News
Earnings
Benzinga
From
Benzinga
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
January 29, 2024
Tickers
AAPL
ABBV
AMD
AMZN
Tags
GOOG
QCOM
CLX
From
Benzinga
Regeneron/Sanofi's Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation
January 26, 2024
Tickers
NEWS
REGN
SNY
Tags
Biotech
Benzinga
Health Care
From
Benzinga
French Drugmaker Sanofi Agrees To Buy Inhibrx's Candidate For Rare Genetic Indication, For About $2.2B
January 23, 2024
Tickers
INBX
NEWS
SNY
Tags
M&A
Market News
News
From
Benzinga
Olympic Sponsor Sanofi Makes Major Play In Rare Disease Arena $2.2 Billion Acquisition Of Inhibrx Project
January 23, 2024
Tickers
INBX
NEWS
SNY
Tags
News
SNY
Sanofi
From
Benzinga
Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
January 22, 2024
Tickers
ACRS
NEWS
REGN
SNY
Tags
General
REGN
Briefs
From
Benzinga
Sanofi's Olympic Endeavor: Leap Into Olympic Sponsorship Signals Cultural Transformation
January 10, 2024
Tickers
CRERF
CRRFY
LVMHF
LVMUY
Tags
CRRFY
News
Large Cap
From
Benzinga
China Approves AstraZeneca-Sanofi's Respiratory Syncytial Virus Drug To Prevent Infection In Infants
January 02, 2024
Tickers
AZN
NEWS
SNY
Tags
General
AZN
Market News
From
Benzinga
Expensive Drugs For Americans In 2024? Drugmakers Including Pfizer, Sanofi Mull Price Increase In January
December 29, 2023
Tickers
GSK
NEWS
PFE
SNY
Tags
GSK
TAK
AI Generated
From
Benzinga
Why First Wave BioPharma Shares Are Skyrocketing Today
December 27, 2023
Tickers
FWBI
NEWS
SNY
Tags
General
Briefs
premarket trading
From
Benzinga
Why Is Eye Disease Related Gene Therapy Focused MeiraGTx Stock Soaring Today?
December 21, 2023
Tickers
JNJ
MGTX
SNY
Tags
Briefs
Biotech
Movers
From
Benzinga
European Drugmaker Sanofi Ends Tusamitamab Ravtansine Lung Cancer Program After Disappointing Data
December 21, 2023
Tickers
SNY
Tags
News
Large Cap
Briefs
From
Benzinga
Looking Into Sanofi's Recent Short Interest
December 21, 2023
Tickers
SNY
Tags
Benzinga
Trading Ideas
Short Ideas
From
Benzinga
First Wave BioPharma To Acquire ImmunogenX To Bolster Gastrointestinal-Focused Pipeline
December 18, 2023
Tickers
FWBI
SNY
Tags
Market News
M&A
General
From
Benzinga
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
December 17, 2023
Tickers
ARCT
CPRX
HRMY
MGNX
Tags
VYGR
MGNX
CPRX
From
InvestorPlace
It's Almost 2024: 3 Top Stocks to Buy Before the New Year
December 17, 2023
Tickers
AMZN
GOOG
GOOGL
KO
Tags
REGN
SNY
MSFT
From
Motley Fool
French Drugmaker Sanofi Secures European Medicines Agency's Positive Opinion For Sleeping Sickness Treatment
December 15, 2023
Tickers
SNY
Tags
Briefs
Biotech
Benzinga
From
Benzinga
3 Stocks to Buy Before 2024 That Can Set You Up For Life
December 14, 2023
Tickers
CCL
GOOG
GOOGL
REGN
Tags
SNY
REGN
CCL
From
Motley Fool
French Pharma Giant Sanofi Drops Rare Disease Drug Pact As Federal Trade Commission Puts Antitrust Obstacle
December 12, 2023
Tickers
SNY
Tags
Market News
Markets
Contracts
From
Benzinga
Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company
December 07, 2023
Tickers
JNJ
SNY
VNDA
Tags
SNY
Briefs
News
From
Benzinga
Sanofi Lays Out Ambitious Plans To Bolster Its Pipeline, Highlights 12 Blockbuster Opportunities
December 07, 2023
Tickers
SNY
Tags
Large Cap
Briefs
News
From
Benzinga
IGM Biosciences Increases Focus On Autoimmune Diseases, Stops All Blood Cancer-Related Studies
December 06, 2023
Tickers
IGMS
SNY
Tags
Small Cap
General
Briefs
From
Benzinga
Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
December 06, 2023
Tickers
MKGAF
MKKGY
SNY
Tags
General
MKGAF
Expert Ideas
From
Benzinga
Investor Demand for Clarity Grows Amid Sanofi's Strategic R&D Shift
December 05, 2023
Tickers
SNY
Tags
Market News
General
Biotech
From
Benzinga
Weight Loss Drugs And Associated Suicidal Thoughts - European Drug Regulator Seeks Clarifications From Drug Makers
December 01, 2023
Tickers
AZN
LLY
NVO
SNY
Tags
LLY
Health Care
NVO
From
Benzinga
How Is The Market Feeling About Sanofi?
November 30, 2023
Tickers
SNY
Tags
Short Sellers
BZI/SHORTHIST
Market News
From
Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
November 30, 2023
Tickers
GILD
SNY
Tags
SNY
Recent Press Releases
Market News
From
Motley Fool
Sanofi/Regeneron's Blockbuster Prescription Drug Dupixent Shows Additional Promise In Chronic Lung Disorder
November 27, 2023
Tickers
REGN
SNY
Tags
REGN
Briefs
Benzinga
From
Benzinga
Antibody Player Dianthus Therapeutics Has Potential Amid Active M&A Landscape in Complement-Focused Firms: Analyst
November 22, 2023
Tickers
ARGX
DNTH
SNY
Tags
Analyst Ratings
Initiation
Markets
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.